Exosome Diagnostics
1585 Broadway
New York
New York
10036
United States
Website: http://www.exosomedx.com/
Email: info@exosomedx.com
81 articles about Exosome Diagnostics
-
EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
5/18/2023
Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported interim results from a previously published prospective, randomized study more than 1,000 patients aimed at evaluating the clinical utility of the ExoDx™ Prostate Test over a 5-year follow-up period.
-
New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space
10/18/2022
Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a proof-of-concept study for a novel exosome-based platform that could monitor key biological changes in astronauts in space.
-
Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test
3/23/2021
Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has completed its clinical validation of an in vitro diagnostic version of the ExoDx™ Prostate test kit enabling self-certification as CE-IVD as of March 22, 2021.
-
Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
3/1/2021
Bio-Techne Corporation announced that Humana has awarded a contract effective April 1, 2021 to its Exosome Diagnostics laboratory, covering the ExoDx™ Prostate test for men.
-
Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer
9/8/2020
Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with Hall of Famer and baseball's all-time "Iron Man", Cal Ripken Jr. This year marks 25 years since Ripken played in his 2,131st consecutive game, eclipsing the thought to be unbreakable record of 2,130 set by the legendary Lou Gehrig.
-
Bio-Techne Announces Launch Of ExoCovid-19 Test For Detection Of SARS-CoV-2 In Patient Samples
7/21/2020
Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus and now offers the ExoCovid-19 test for detection of the virus in patient samples.
-
Bio-Techne And ZERO - The End Of Prostate Cancer Announce Partnership To Fund Education And Awareness Campaigns To Empower Men With Prostate Cancer
6/11/2020
Bio-Techne Corporation announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer.
-
Bio-Techne Corporation Completed Its Acquisition of Exosome Diagnostics, Inc.
8/1/2018
Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc.
-
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic
3/16/2018
Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics, to design and validate an assay for use in Intezyne's upcoming Phase 1/2 clinical trials of IT-139
-
Exosome Diagnostics To Present A Novel Atlas Of Exosomal Mrna And Long Non-Coding RNA Across Biofluids At American Society Of Exosomes And Microvesicles Annual Meeting
10/11/2017
-
Massachusetts' Exosome Diagnostics Snags $30 Million
7/25/2017
-
Exosome Diagnostics Announces Early Access Program For “Shahky” - Exosome Protein Interrogation Instrument
2/3/2017
-
Exosome Diagnostics Release: Company Obtains ISO 15189 For Its Munich Laboratory
1/18/2017
-
Exosome Diagnostics Presented The Highest Sensitivity Liquid Biopsy Test For Lung Cancer
12/21/2016
-
Exosome Diagnostics Enters Agreement With Amgen
10/3/2016
-
Exosome Diagnostics Appoints Elizabeth Cormier-May As Head Of Commercial Diagnostics
9/13/2016
-
Exosome Diagnostics Enters Partnership With Takeda
6/30/2016
-
Exosome Diagnostics Appoints Mario Morken As Director Of Business Development
6/27/2016
-
ASCO2016: Exosome Diagnostics Presents Data On Novel Platform For Disease- Specific Exosomes
6/8/2016
-
Exosome Diagnostics Announces Key Appointments To Informatics Group
6/6/2016